TRACON Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 Nov 23 | SellUS$1,401,571 | Opaleye Management Inc. | Company | 238,200.4 | US$5.88 | |
27 Apr 23 | BuyUS$37,889 | Charles Theuer | Individual | 2,549.95 | US$15.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 518 | 0.0228% |
Individual Insiders | 58,702 | 2.58% |
Institutions | 124,282 | 5.46% |
Hedge Funds | 133,547 | 5.87% |
General Public | 1,958,176 | 86.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 91%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
133,547 | US$247.1k | -3.42% | 0.07% | |||
35,846 | US$66.3k | -35.8% | no data | |||
20,695 | US$38.3k | 0% | no data | |||
20,613 | US$38.1k | 0% | no data | |||
20,321 | US$37.6k | 0% | no data | |||
13,138 | US$24.3k | -57.6% | no data | |||
13,063 | US$24.2k | -2.45% | no data | |||
12,942 | US$23.9k | 0% | no data | |||
10,439 | US$19.3k | -2.08% | no data | |||
9,572 | US$17.7k | 0% | no data | |||
4,901 | US$9.1k | -27.1% | no data | |||
4,200 | US$7.8k | 0% | no data | |||
4,071 | US$7.5k | -96.5% | 0.17% | |||
3,757 | US$7.0k | 0% | no data | |||
2,872 | US$5.3k | 0% | no data | |||
1,256 | US$2.3k | 0% | no data | |||
1,084 | US$2.0k | 0% | no data | |||
789 | US$1.5k | 0% | no data | |||
767 | US$1.4k | 0% | 100.0% | |||
650 | US$1.2k | 0% | no data | |||
602 | US$1.1k | 0% | no data | |||
518 | US$958.4 | -0.38% | no data | |||
512 | US$947.1 | 0% | no data | |||
388 | US$717.7 | 0% | no data | |||
175 | US$323.7 | 0% | no data |